Avacta Group plc (LON:AVCT), the developer of Affimer® biotherapeutics and reagents, has announced the appointment of Neil Bell as Chief Development Officer of Avacta Life Sciences with immediate effect. Neil will
Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine to clinically validate the rapid, saliva-based coronavirus antigen test that Avacta is developing with Cytiva. The
Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss the appointment of BBI Solutions as manufacturing partner for the COVID-19 test. Alastair talk us through the details, how the
Avacta Group plc (LON:AVCT), the developer of Affimer® biotherapeutics and reagents, has announced that it has entered into a collaboration with the Liverpool School of Tropical Medicine (LSTM) to clinically validate
Avacta Group plc (LON:AVCT), the developer of Affimer® biotherapeutics and reagents, has announced that it has appointed BBI Solutions, part of BBI Group, to manufacture the saliva-based rapid SARS-CoV-2 antigen test
Coronaviruses are a large family of viruses that cause illnesses like the common cold, but can also cause more severe diseases such as Middle East Respiratory Syndrome (MERS) and Sever
Avacta Group plc (LON:AVCT), the developer of Affimer® biotherapeutics and reagents, has announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co. Ltd. and AffyXell Therapeutics, the joint venture
Testing Therapies, Antivirals and Vaccines Avacta Group has partnered with the U.K. government’s CONDOR program to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry laboratory assay developed with
Sewage monitoring is being trialled as a way to spot new outbreaks of coronavirus, and three UK companies have now joined forces to try to develop a probe for this
All health and care staff should be routinely tested for Covid-19 once or twice a week, according to one of the UK’s most eminent scientists, Sir Paul Nurse, whose team’s
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
